Witnessing the stock’s movement on the chart, on May 24, 2023, Teva Pharmaceutical Industries Limited (NYSE: TEVA) had a quiet start as it plunged -1.56% to $7.57. During the day, the stock rose to $7.65 and sunk to $7.50 before settling in for the price of $7.69 at the close. Taking a more long-term approach, TEVA posted a 52-week range of $6.78-$11.44.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been -7.80% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 34.30%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -662.70%. This publicly-traded company’s shares outstanding now amounts to $1.11 billion, simultaneously with a float of $1.10 billion. The organization now has a market capitalization sitting at $9.19 billion. At the time of writing, stock’s 50-day Moving Average stood at $8.59, while the 200-day Moving Average is $9.17.
It is quite necessary to find out the efficiency of the corporate organization, which has 34004 number of employees on its payroll. It has generated 1,360,727 per worker during the last fiscal year. Meanwhile, its income per employee was -214,683. The stock had 3.69 Receivables turnover and 0.33 Total Asset turnover. For the Profitability, stocks gross margin was +46.68, operating margin was +17.96 and Pretax Margin of -20.55.
Teva Pharmaceutical Industries Limited (TEVA) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Drug Manufacturers – Specialty & Generic industry. According to the most recent insider trade that took place on Mar 07, this organization’s EVP, North America Commercial sold 58,066 shares at the rate of 9.43, making the entire transaction reach 547,440 in total value, affecting insider ownership by 165,381. Preceding that transaction, on Mar 07, Company’s Exec. VP, European Commercial sold 54,007 for 9.43, making the whole transaction’s value amount to 509,173. This particular insider is now the holder of 69,770 in total.
Teva Pharmaceutical Industries Limited (TEVA) Earnings and Revenue Records
As on 3/30/2023, Multinational firm has announced its last quarter scores, in which it reported $0.4 earnings per share (EPS) for the period falling under the consensus outlook (set at $0.56) by -$0.16. This company achieved a net margin of -15.78 while generating a return on equity of -26.42. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.61 per share during the current fiscal year.
Teva Pharmaceutical Industries Limited’s EPS decrease for this current 12-month fiscal period is -662.70% and is forecasted to reach 2.46 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 1.60% through the next 5 years, which can be compared against the 34.30% growth it accomplished over the previous five years trading on the market.
Teva Pharmaceutical Industries Limited (NYSE: TEVA) Trading Performance Indicators
Let’s observe the current performance indicators for Teva Pharmaceutical Industries Limited (TEVA). It’s Quick Ratio in the last reported quarter now stands at 0.70. The Stock has managed to achieve an average true range (ATR) of 0.29. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.62. Similarly, its price to free cash flow for trailing twelve months is now 9.53.
In the same vein, TEVA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.44, a figure that is expected to reach 0.53 in the next quarter, and analysts are predicting that it will be 2.46 at the market close of one year from today.
Technical Analysis of Teva Pharmaceutical Industries Limited (TEVA)
Going through the that latest performance of [Teva Pharmaceutical Industries Limited, TEVA]. Its last 5-days volume of 30.48 million indicated improvement to the volume of 10.73 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 5.16% While, its Average True Range was 0.30.
Raw Stochastic average of Teva Pharmaceutical Industries Limited (TEVA) in the period of the previous 100 days is set at 1.77%, which indicates a major fall in contrast to 4.09% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 45.39% that was higher than 40.45% volatility it exhibited in the past 100-days period.
